YS

Active Director Director DIN 10686020
DIN 10686020 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Yash Seth

Data last updated:

Yash Seth is a Director at Gopal Life Sciences Private Limited (since 2024). The company operates in Pharma. Gopal Life Sciences Private Limited reported revenue of ₹60 Lakh (FY 2025).

DIN 10686020
Primary Designation Director
Industry Pharma
First Appointment 27 Jun 2024
Oldest Company Age 2 yrs
Largest company Gopal Life Sciences Private Limited · ₹60 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gopal Life Sciences Private Limited U46497UP2024PTC205439
Director27 Jun 20242024₹60 Lakh (FY 2025)Active

Board colleagues of Yash Seth

NameDINCompanyDesignation
Manish Seth10686021Gopal Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gopal Life Sciences Private Limited
Premium access

Shareholding and investment profile for Yash Seth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yash Seth

Yash Seth currently holds 1 directorship: Gopal Life Sciences Private Limited (Director, since 27 Jun 2024, revenue ₹60 Lakh (FY 2025)).

Yash Seth was first appointed on 27 Jun 2024 as Director at Gopal Life Sciences Private Limited.

The current boards of Yash Seth's companies include Manish Seth (Gopal Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available